PLCB1 and cancer: In the analysis of The Catalogue of Somatic Mutations in Cancer, Mark G. Waugh demonstrated that the change in the number of gene copies of PLCβ1, as a component of phosphoinositide pathway, is involved in GBM; however, their conclusion that GBM cells gain PLCβ1 gene copies is different from our findings [43].